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Proposed Guidelines for the Internal Quality Control of Analytical Results 
in the Medical Laboratory
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on analytical quality goals in laboratory medicine
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Cal him F raser6 and Linda Thienpont1
1 K linisk B iokem isk  Afdeling, Odense Universitetshospital, Odense C, D enm ark
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Summary: The factors involved in analytical quality relate to definition o f  quality , creation o f  qua lity , and  control 
o f  quality, and errors arise from external and internal sources as well as from  p e rm an en t an d  variab le  factors. 
Further, the tw o main types o f  error are classified as systematic and random  errors.
Internal quality  control (IQC) systems can only operate on the variable factors w hich  are re la ted  to  ba tch -to -ba tch  
variations (external factors) and to the perform ance in the laboratory (internal factors).
In creating an adequate internal control system, several problem s are faced:
(i) quality  o f  control materials,
(ii) types and frequency o f  possible errors,
(iii) num ber and types o f  control materials,
(iv) num ber o f  replicates o f  the control,
(v) probability  o f  errror detection,
(vi) probability  o f  false rejection,
(vii) consequences o f  reject signals,
(viii) trouble-shooting  systems, and
(ix) prevention o f  errors am ong many other conditions.
Gaussian d istributions o f  control results are assumed and the statistical control rules are  ev a lu a ted  in re la tion  to 
probability o f  false rejections, Pfr, and probability o f  error detection, Ped, fo r the d iffe ren t ru les. C o m b in a tio n s  o f  
low P,v and high Petl are obtained by com bining results from  e. g. four m easurem ents  o f  the  sam e contro l sam ple
by use o f  m ean and range rules.
Further, it is not possible to establish a com m on control system  w hich  can  b e  used  fo r all quan tities  an d  analy tica l 
procedures; on the contrary, each procedure should have its particular efficient IQ C  system .
These aspects are discussed and a num ber o f  guidelines for statistical control n d es  an d  p ro b le m  re la ted  in ternal 
quality control are presented.
l ) This paper was prepared by a working group (WG-A) which is 
one o f  lour groups created under the auspices of the European 
External Quality Assessment Organizers (European EQA-Organiz­
ers). The working groups were initiated by Adam Uldcill, Denmaik 
and set up following a meeting o f  EQA-Organizers and interested 
individuals in Cracow, Poland, in 1991 at Eurolab ’91.
2) Present address: Laboratorium voor Analytische Chemie, Facul
teit Farmaceutische Wetenschappen Universiteit Gent, Gent, Bel
gium
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Introduction S p e c if ic a t io n  o f  a n a ly t ic a l  qua l i t y
Internal quality control (IQC) of analytical processes ^ * s necessary to know what we undei stand by analytic
was introduced in clinical chemistry as Levey-Jennings caI quality in order to judge the quality of a ceitain
charts (1) based on Shewharfs theories (2) for ‘econom- analytical procedure. Within laboiatoiy medicine many
ical control of quality o f the manufactured products’, different approaches to the definition of the quality le-
The control was based on the Gciass\%n (normal) distri- quired have been introduced with a vaiiety of speciflca-
bution using the x ±  2 s (mean +  or — twice the stan- tions. These have recently been assessed by the Woiking
dard deviation) rule for acceptance or rejection o f  an Group (12) and the biological concept was chosen ac-
analytical run. In 1977 Westgard and ‘the Uppsala- cording to its well documented basis, its simplicity, and
group’ (3, 4), however, pointed to the fact that about 5% ^ s universal application. These lecommendations are for
of results from stable runs (series) would be rejected maximum allowable analytical impiecision (coefficient
without logical reasons — except by virtue of the chosen ° f  variation), C V ana]ytjCai:
control rule — and the situation would be even worse if 
several measurements o f the control samples were intro-
^ ^analytical ^  0.5 X CDithin-suItjcct
duced in the same run because the proportion of false wheie CVWithi„-Subject iS ths biological within subject
rejects would increase rapidly. Therefore, they investi- variation estimated from healthy individuals, and for
gated the different control rules by computer simulations maximum allowable analytical bias (in / o ), Biasmia|yUca), 
and, in their paper from 1979 (5), the theory was made w^en imprecision is negligible,
completely clear through the application o f power func­
tions, Since then, several papers from this group and 
others have been published in addition to books (6 — 8); 
moreover, what have become known as 'Westgard's 
rules’ have been introduced in the software of many ana­
lytical systems. The reader is further referred to some 
papers o f Linnet (9, 10).
It should be mentioned, however, that control does not 
necessarily imply quality, since control by itself can only
Biasanaiytica] ^  0,25 X
C VftetWC0n_subjCC()
wheie (CVwjthjn.subject ^Vbeiweon_Subject) t'he com­
bined biological within- and between-subject variation. 
The recommendation also implies specification for max­
imum allowable systematic error, ASE (to be explained 
in detail below), when imprecision is negligible:
ASE <  0.33 X CVwiUiin>subjcel
be used in monitoring o f the current quality of the pro- However, when clear and specific clinical strategies for
cess, e. g. by rejection o f  certain errors — but it cannot diagnosis and treatment are defined, as for serum cho-
improve the analytical quality properly. To improve the lesterol (13) and for blood HbAjc (14), then analytical
quality of the analytical procedure, introduction of better quality specifications should be based on the maximum
methods and calibrators are needed.
The purpose of this paper is to outline aspects of analyti­
cal quality in relation to internal control o f  analytical 
quality, to assess analytical cohtrol rules, and to provide 
guidelines for the optimum use of internal control sys­
tems .
acceptable diagnostic misclassifications. Nevertheless, 
such strategies are few and the biological concept is, 
therefore, the best basis for general quality specifica­
tions for the majority of the quantities (components) in 
laboratory medicine.
Elements of Analytical Quality
C r e a t i o n  of  a n a l y t i c a l  qua l i t y
The creation of analytical quality is based on external as 
well as internal factors and on permanent and variable
illustrated in figure 1.
Three aspects can be delineated as the main factors in- factors as described previously (15, 16) and by the
volved in analytical quality. These are specification o f  Working Group in relation to external assessment (17);
analytical quality, creation o f  analytical quality, and these are illustrated in table 1.
con tro l o f  analytical^ q u a lity  (11 ) and are inter-related as The quality of the extemal factor8 flro beyom, ,hc contm,
of the individual laboratory and, in this regard, each lab­
oratory must try to choose the most appropriate methods 
(reagents, instruments, calibrators) from those available 
on the market. This is a difficult task as there is no 
institution which publishes lists of the quality of com­
mercial products. External assessment schemes which 
summarize results from the participants ordered accord­
ing to methods and instruments may be of some help 
(17), but the concept based on split-sample measurement 
of patients samples with both reference and routine
Spec locations
for analytical 
quality
Creation 
of analytical 
quality
Control 
of analytical 
quality
Fig. 1 Elements of analytical quality.
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Tab. 1 Factors involved in creation of analytical quality
External Internal
Permanent Method:
Analytical principle
Equipment
Reagents
(choice of producer)
Standard iza tion: 
Traceability of calibration
Implementation:
Choice of conditions 
fcIn house* equipment 
‘In house’ reagents,
Time, Temperature, Volume, etc,
Standardization :
Calibration function
Variable Batches:
Reagents (variability)
Calibrators
Consumables
Performance:
‘In house’ reagents 
Training, Maintenance, etc. 
Control with ‘trouble-shooting’ 
Documentation
\
methods for evaluation of commercial methods/kits (18) 
seems to provide a solution to this problem for the quan­
tities where accepted well documented reference meth­
ods exist.
The individual laboratory, on the other hand, is directly 
responsible for its internal factors. First, by correct im­
plementation of the methods, and later through monitor­
ing of analytical quality and detection of errors.
A. Types o f analytical errors according to their sources
Before considering internal control systems it is neces­
sary to define the various types of errors. The errors 
related to the permanent factors (tab. 1) can not be dis­
closed by any internal control system without help from 
external quality assessment (EQA) systems (17) or from 
information of method evaluation groups (18), so the 
internal control system can only disclose changes in the 
variable factors. Two types of errors (changes in the 
variable factors) can be identified, i. e. external and in­
ternal errors, respectively, and these must be treated dif­
ferently as described below.
A. a. Frequency o f internal analytical errors
The frequency of analytical errors cannot be known pro- 
spectively but documentation of all errors allows a retro­
spective estimate to be made, and hence a forecast for 
the expectation in the near future. This future frequency 
of errors should, however, be reduced by the following 
procedure. The types of errors are decomented together 
with frequency of each. For the errors which are easy to 
prevent, a fail-safe procedure is established and docu­
mented in the standard operating procedure of the labo­
ratory. Examples are
a) reagents which can be mixed up (e, g. antibodies for 
immunoassays) are separated (kept in different freezers) 
or identified by colour coding,
b) unstable reagents are used in smaller volumes or not 
used after a well-defined time;
c) unrealistically small volume pipettings are replaced 
by larger more reliable volumes;
d) unsatisfactory calibrators (and controls) are changed, 
etc.
Then the most frequent o f the more complicated errors 
should be tackled. It may be more difficult if the prob­
lem is related to expensive components, e. g. the equip­
ment, but more frequent maintenance may reduce the 
frequency of errors — and replacement should be antici­
pated in the budget.
A.b. Frequency o f  variable external errors
As for internal analytical errors it is not possible to know 
the frequency of external errors — but it is known that 
they can be expected when a new batch of reagents is 
taken into use. Therefore, particular attention should be 
scheduled for every change o f lot or batch, in order to 
reject these if unacceptable, and procure further supplies 
in good time, i.e., while the old batch is still in use. 
Batch comparison should be made by parallel analysis 
with the same samples and at the same time. An old 
batch should not be exhausted before a new one is ac­
cessible for comparison,
B. Types o f analytical errors according to their effects
Further, errors can be related to random error and sys­
tematic error (19).
B.a. Random error
The random error (“result of a measurement minus the 
mean that would result from an infinite number of mea­
surements of the same measurand carried out under re­
peatability contitions” according to VIM (19)) can be 
separated into inherent variation o f the analytical pro­
cedure as implemented in the laboratory and increase in 
this variation due to changes in the performance (caused 
by changes in consumables, reagents, technique, etc.). 
This change in imprecision is quantified by a factor RE
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or ARE according to Westgard et al. (3), where ARE known) wavelength (when wavelength is not shifted). In 
indicates the factor by which the inherent imprecision such cases, the type and size o f the error is predictable, 
is increased. When errors exceed the analytical quality specifications,
the run should be rejected, whereas, minor errors should
B.b. Systematic error not lead to such consequences. One consequence of mi-
The VIM-definition o f systematic error (“the mean that nor (in PrinciPle ~  tolerable) errors is, however, a higher
would result from an infinite number o f measurements frequency o f rejection, which in this context may be
of the same measurand carried out under repeatability considered .superfluous rejections -  in order to distin-
conditions minus a true value of the measurand”; VIM §u’sh them from the so' called false ejections as de-
(19)) is not sufficient for laboratory medicine. This is sclibed below.
due to the possible sources o f errror which may be re­
lated either to the calibration (and some common as- tyPes o f errors
pects o f  performance) which is the same foi all mea- analysts are asked about the most important errors
sured samples in a run, or to individual (but leproduc- ¡n tjie ia50rat0ry, they will often rank specimen mix-up
ible) deviations due to non-specific reactions oi intetfer- anc| incorrect factors applied to diluted samples highly.
ing substances in the vaiious patient samples (and often Pre-analytical as well as post-analytical errors, however,
diffeient from the control samples). The systematic er- cannot be disclosed by analytical control systems and
101s caused by non-specific leactions and interferences they ai*e outside the scope of this document, 
(aberrant-sample bias (20)) can be disclosed only by
specially designed control systems with selected control 
materials, e. g. samples from patients with well known
pathological composition of interfering substances. This Before going into details of control systems, it is impor-
type o f evaluation is best performed in external quality tant to note that the control systems described below are
assessment (EQA) surveys (21) or by more direct co- not always the best for error detection as other checks,
operation with producers of reagents (18). In conse- like visual inspection of pipettes or check of counts/min
quence, only ‘calibration-type’ systematic errors can be (or absorbance) of one of the dilutions of the calibrator,
dealt with in internal control systems, and this is quanti- may be more powerful. Furthermore, when the main
fied as ASE, where ASE denotes the size of systematic problems are identified, then error prevention may be
error, i.e. the factor in units o f standard deviation (for more important (and often cheaper),
Problem-related control
inherent variation) by which the whole run is dislocated.
C. Further characterization o f  analytical errors
C.a. Persistent errors
Stable Perform ance and Errors
Stable performance is characterized by the laboratory’s
Analytical errors can be persistent, i.e. be present for bias [both bias common to all samples due to e.g. cali- 
longer periods (22, 23). One example is when there are biation (calibiatoi and calibiation function) and the indi­
problems with a certain batch of a reagent, where the v^u a l bias foi each patient (and contiol) sample due to
error will continue until the batch is changed. Persistent sPec^ lc^y and to inteiference in the measure-
errors are relatively easy to discover as they will be re- nients (matrix effects)] and by landom variation, the in-
peated day after day and the start can often be related to he}ent imprecision (deteimined by the analytical prin­
ciple, equipment, etc. and the implementation in the lab­
oratory).
Errors are usually defined as the deviation from the con-
a change which has been documented in the log-book.
C.b. Intermittent errors
/  * /
Intermittent errors (22, 23) are difficult to identify as it ventional true value, but in internal control, only devia- 
is often impossible to reproduce the error. Furthermore, tions from the stable performance can be disclosed. The 
this type of error may be unnoticed if  the control system VIM definition, “deviation” (19), is not specific for
Itqp th f i s e  tv n f i s  n f  n r n h l  p.rrw s n  thf* n n m p n r l i i t i i r# *  nnHin#»rl h vlias insufficient power.
D . Size o f  analytical errors
t es  types of problems so t e o enclature outlined by 
Westgard et al. (3, 4) will be retained for the purpose of 
defining and inteipreting internal errors and control.
The sizes of analytical errors o f course cannot be pre- Errors are here defined as deviations from stable perfor-
dicted in general but detailed knowledge of the steps in mance. Systematic errors, ASE, are deviations, common
the analytical procedure may give an estimate. Thus, to all measurements, and random errors, ARE, are in-
when two different quantities are measured on one and creases in the inherent imprecision (in principle the A is
the same instrument using two different wavelengths, a not correct for random errors, but is used currently in
frequent error might be measurements at the other (and the literature).
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Control of Analytical Quality The quality of control materials is of major importance
Control can be divided into internal quality control and for the quality of the CQntro1 itself- Therefore, the pur-
external quality assessment according to two separate Posc ^le contro' should be known in order to select
purposes. Internal quality control can only be used for ^ie aPP'°Pr*ate control material (25, 26). For internal
monitoring the variable factors -  and external quality quality contro1 there are two main strategies: control o f
assessment is best for evaluation of the permanent the variahle external factors andcontrol o f  the stability
factors as illustrated in figure 2 .
Creation 
of analytical 
quality
Control 
of analytical 
quality
Fig. 2 Illustration of the relations between the Factors involved in 
the creation of analytical quality (permanent and variable) and in 
the control of analytical quality (external assessment and internal 
control).
External quality assessment systems may assist evalua­
tion of internal quality control but, in general, external 
systems are too slow for the ongoing monitoring of per­
formance.
o f  the performance. As described above (fig, 2), the per­
manent factors^ such as the traceability of calibrator, an­
alytical principle, and the implementation in the labora­
tory of the method cannot be controlled by internal con­
trol -  this process needs an external system. In prin­
ciple, laboratories can buy (expensive) reference 
preparations, but this must be considered an external as­
sessment; these are independent o f EQA or may be a 
step in the process of quality improvement, and thereby, 
outside the scope of internal control. However, in the 
case that much cheaper commutable IQC materials with 
reference method target values are available in the fu­
ture, traceability can also be controlled internally. The 
dilemma of expensive commutable materials with trace­
able values might be solved if these materials are used 
for internal control as well, which would need much 
greater volumes and thereby — maybe — cheaper mate­
rials. Genuine (non-processed) serum with traceable 
target values is, however, difficult to handle. It must be 
stored at -  80 °C and mailed on dry ice, as in the Nordic 
protein project ( 11), so further efforts are needed to 
solve this.
In principle control rules do not differ, irrespective of 
whether used for detection o f the variable external errors
External quality assessment relates to stable perfor- Qr but trouble. shooting and possibilities
for correcting errors are different for these, in order to 
detect external variable errors, a painstaking record on
mance and it is described in detail in other documents 
from this Working Group (17, 24).
Internal quality control thus relates to detecting or dis- each batch is needed and in principle every new batch 
closing deviations from stable performance in the indivi- should be tested before use (cf. ISO 9000-series). A fo­
cus should be kept on changes in the external factors 
and the control results interpreted accordingly. The same 
should be the case for internal changes but here many 
other factors are involved so the maintenance of the ana-
dual laboratory.
Creation 
of analytical 
quality
Internal control 
of analytical 
quality
Assumptions for Internal Quality Control
In laboratory medicine, samples used for internal quality l^ c a l  procedure may be as important as the internal
control are selected samples with values usually known 
by calculating the mean from several measurements of 
the sample under ‘stable conditions’ in the same labora­
tory. This means that it is an indirect control -  in con­
trast to many industrial products where the performance 
of the product itself can be controlled directly, e.g., 
screws and cars, where the characteristics can be mea­
sured directly (length, speed etc.). In consequence, the 
•esult of the control does not always reflect the quality
C orrection 
of e rro rs
1
of the assay of patients samples since lack of precision 
has different and random effect on the samples during 
the measurements -  and will be random again if the 
measurement is repeated. Further, interfering substances 
in patient samples may not be reflected by the control
samples.
Prevention 
of errors Trouble-shooting
Fig. 3 Model for reaction-pattem for rejection-signals from the 
internal control system: When a rejection signal occurs, then trou­
ble-shooting should start and the error(s) should be corrected. 
However, this should lead to establishment of fail-safe procedures 
in order to prevent these types of errors in the future.
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control. The relationships between internal control, trou- able literature. Here only the strict interpretations ot 
ble-shooting, correction o f  error, prevention o f  errors such signals will be found. The way to investigate this is 
(fail-safe procedures), and establishment of creation o f  to listen to discussions among analysts or to ask indirect
(better) analytical quality are outlined in figure 3.
It is essential to understand that internal control has its 
limitations and that it is only a part o f  the quality of the 
analytical process — but it is a very important tool for 
detecting errors in each batch and changes in perfor­
mance when it is handled correctly and with care and re­
flection.
questions; otherwise the problems will be missed. How­
ever, interpretation is often different for various equip­
ment in the same laboratory and it is difficult to be ob­
jective about how the patterns were introduced.
Materials for Internal Control
Examples o f  reaction patterns for reject signals
a. The general type
The general type is an immediate rerun of the series. 
This is also the generally accepted concept for handling 
The most important characteristic o f any material used reject signals. However, this pattern is as bad as many 
for internal control is its ability to reflect deviations from other reactions (except for a few situations as described 
stable analytical performance. Therefore, it must be sta- below). The reasons are because there are two possibilit- 
ble and reproducible, i. e., the measurand must be in ex- ies:
actly the same molecular form and the same concentra­
tion each time it is used for control — and the surround­
ing components (the matrix) must also be identical. 
These characteristics are indispensable for materials to
a) either the run was satisfactory and it was a false rejec­
tion due to a poor control rule which results in the work 
being unnecessarily doubled, or
be used for internal control according to the statistical b) there was an error and then it is not expedient to 
control rules described below, Control materials, e. g. for repeat the error and so again the work is doubled un­
serum analyses with composition close to genuine se- necessarily.
rum, are usually better than artificial materials if  they 
are stable and reproducible. There have been no com­
mercial QC-materials available until now with these 
quantities, but in many laboratories pools with fresh se­
rum from healthy individuals are used for internal con­
trol of serum proteins and a number o f hormones. In 
some countries, the use of single donations o f patient 
serum or serum pools is also allowed. In view of the 
above mentioned limitations lyophilized material is 
often preferable to other materials, but the reconstitution 
of the volume must be painstakingly performed. This is 
in contrast to external assessment, where genuine con­
trol materials are superior to other materials (25, 26). 
Likewise, ‘true* concentration values are not essential 
for internal control provided that the target values are 
determined under optimal conditions (stable perfor­
mance). The assignment of values could be performed 
while high quality calibrators are used for calibration
The relevant solution to the problem is to introduce con­
trol rules with low probability o f false rejection as de­
scribed below and, when these are established, then the 
reaction to reject signals should be, to stop the work -  
start trouble shooting -  correct the error — and, i f  pos­
sible, implement a fail-safe procedure as illustrated in 
figure 3. Most will recognize subjective decisions, for 
example, where the analyst says that a method has been 
re-run three times and the control is still outside the 
acceptance limits. Then it might be said (after considera­
tions) that the error is without clinical importance and 
the report shall be issued\ Of course, clinical relevance, 
and thereby the size of acceptable error, should have 
been decided beforehand (based on thorough and careful 
considerations) when the analytical quality specifica­
tions were outlined and the control rules were intro­
duced and not in stressed situations.
and/or external assessment with high quality materials It may be a troublesome process to identify the many 
is performed. This could take place over, e. g. 20 analyti- different errors and find fail-safe procedures -  but it is 
cal runs co-ordinated with the yearly external assess- die best way to solve problems and to eliminate the il- 
ment as described by Libeer et al. (17). Internal control logical feeling of doing a good job when re-running sev- 
is thus linked to the external assessment and both are eral times and performing doubtful decisions based on 
indispensable for documentation and monitoring o f  the incomplete facts, 
analytical quality,
Exceptions from the strict pattern of trouble-shooting 
are systems with multiple channels and procedures
Reaction P a tte rn s  fo r IQ C  Rejection Signals where the analyticai time for a sinSle measurement is
veiy short and samples are processed separately, e.g.
When reaction patterns for actions taken on reject sig- many haematological analyzers and near-patient instru- 
nals are considered, it is of little help to search the avail- ments. Here, it is so easy to repeat the control measure-
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ment that it is logical to do this before trouble-shooting 
is started (see below).
b. The overlook type
The overlook type is the lack o f reaction to reject-sig- 
nals. This situation is not intended, but arises under cer­
tain conditions, e. g. when the control system has a very 
high frequency of false rejects or a persistent error has 
lasted (uncorrected) for a long time. This could be a 
batch of low quality or a control material with a poorly 
defined target value. In the latter case, the neglect of 
reject-signals might be correct, but this is not known.
c. The multi-channel type
The multi-channel type is related to the high frequency 
of repeated testing (control signals) performed in multi­
channel analyzers, when the control rules are not ad­
justed for each of the many tests. The probabilities of 
rejections according to the number of repeated testings 
using this control rule are listed in table 2 .
Tab. 2 Probability o f  false rejection o f  runs in relation to num ber 
o f  repeated analyses
Number 
o f  repeated 
analyses
Probability o f  false rejections 
P fr for x ±  z X s
x ±  1.96 s x ±  2 s
1 5% 4.6%
2 10% 8.9%
5 23% 20 .8%
10 40% 37.2%
20 65% 60.6%
P jV(repeated) =  1 -  [1 — Prr(single)]n, where n is the number o f  
repeated analyses and P fr in the formula is measured in fraction.
Some laboratories make recalibrations of all runs by use 
of the ‘controls’, whereas others “only” recalibrate when 
the control is outside the x ±  2 s limits. In both situa­
tions the rejection rate is reduced, but at the same time 
the analysis is without any kind of control system and 
the quality is unkown. Again the solution is to establish 
proper control rules with low probability of false rejects.
cL Other types
Several other types of handling control systems wrongly 
may be possible, but it is more interesting to evaluate 
the correct control systems.
atic or random, should be reflected to the same extent 
in the results for both patient and control samples. Thus, 
the control result is an indicator of the quality of the run 
and, hence, of the quality o f the patient results. This 
is not completely true for random errors as they vary 
independently and it is interesting in the situation where
the control has an ‘abnormal* result which is.actually
still a component of the stable performance. With a con­
trol rule of x ±  2 s this will happen in about 5% of all 
runs, resulting in a reject o f a run which in principle is 
acceptable. By using another control rule, e. g. x ±  3 s 
(mean ±  3 s), the probability o f false rejects \  Pfn will 
be reduced to 0.3%. Thereby, the unnecessary rejects are 
reduced considerably, but at the same time the prob­
ability o f error detection, Ped> is also reduced. The P fr 
and the Ped are functions of the control rules and, by 
selection of reliable control rules, the analytical work 
can be smoothed and also be more reliable. The Pfr-val- 
ues for a number of simple control rules of the type 
x ±  z X s are listed in table 3.
Lack of understanding o f the basic concepts of statistical 
control rules has led to some illogical procedures as de­
scribed above. By choosing the relevant control rules for 
the internal control system, however, it becomes pos­
sible to introduce systems with control rules which can 
keep the Pfr low and at the same time allow for a high 
Ped as described below.
C o n t r o l  ru l es
Both patient samples and controls are assumed to be 
distributed randomly (Gaitssim) during an analytical 
run. This means that a control result may be outside the 
control limits — according to the Pfr — whereas patient 
samples are determined correctly, and vice versa. There­
fore, the purpose of the design of control rules is to 
distinguish between false rejections and errors, and often 
to indicate the type of error (random or systematic); in 
consequence, trouble-shooting procedures have already 
started. As long as only one control sample in single 
determination is used, the possibilities are limited to 
control rules of the type % ±  z X s -  but an understand­
ing of the simple rules is important for more complex 
concepts. Understanding Prr should be easy from table 3
T ab . 3 Probability of false rejection w ith  a single analysis using 
control rules o f  the type x i z X s
Control rule Probability
o f  false
rejection, P fr
5 %  (4.55%) 
1%
0.3%
0.05%
0.01%
Theorectical Basis for Statistical Control Rules
The inherent imprecision is assumed Gaussian in nature _
and also the whole theory is based on this assumption. . x + 2.575 s 
Results from both patient samples and controls are as- x ± 3 s 
sumed to vary independently according to the inherent * * 3.5s
imprecision. In principle any deviation, whether system- _ Z ---------
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and the interpretation of Ped becomes clear from the Figure 4 illustrates the effect of increasing systematic
power-functions (see below).
P o w e r  f u n c t i o n s
For a certain control rule and a certain type of error the 
probability of detecting the error, Ped, can be obtained 
from statistical tables or estimated from computer simu­
lations.
One con tro l va lue  o n ly
errors (all with the same original s). The shadowed areas 
denote the probability of rejection which is projected to 
the plot below, the power-function. The extreme situa­
tion of no error (ASE =  0) is the point of P*y, whereas 
the rest of the curve describes the continuous Ped-func- 
tion. When the systematic error exceeds the control limit 
(3 s) by more than 2 times the standard deviation, i. e. 
for ASE >  5, then the Pcd exceeds 97.5%, which means 
that a systematic error of this size will rarely be missed 
by the control system (only one out of 40). The power
By combining Ptv and P ^  as a function of the sizes (and for detecting negative systematic errors is identical to 
types) o f errors in a plot it is possible to get a clear the positive errors.
picture of the relationships by the resulting pow er-func­
tions  as illustrated for systematic errors in figure 4 and 
for random errors in figure 5, using two different control
rules, mean 
respectively.
3 or 2 times the standard deviation,
Systematic error
Control rule: ASE Ped
+5 97.5 %
+4 84 %
+3 50 %
+2 16 %
+1 2.5 %
Pfr = 0.3 %
Percentage 100_,
8 0 -  
eject 60 - 
4 0 -
ed
0 1 A SE (units of s)
Fig. 4 Illustration of the relationship between systematic errors 
(upper left) from ASE zero to +  5 s and (lower) power function 
for the control rule x ±  3 s. The Pcd~values are shown (upper right). 
The ordinate, P^ecu denotes and the single point of P1V.
Random error
Control rule:
ARE Ped
4 62 % 
3 50 % 
2 32 %
Pfr = 5 %
Fig. 5 Illustration of the relationship between random error from 
ARE = 1 (inherent imprecision =  s) to 4 and power function for 
the control rule x ± 2s. Composition as in figure 4.
Compared to control systems for systematic errors, these 
simple control rules are less powerful for random errors 
of considerable sizes as the curve only slowly ap­
proaches the 100% line (figure 5). The powers for de­
tecting the two types of errors are thus different but, as 
only one control rule has been used, the Pfl. is related to 
the control rule only (0.3% in fig, 4 and 5% in fig. 5), 
which means that P tv only depends on the control rule 
chosen. A series of power functions for systematic errors 
are shown in figure 6 .
Control rules: x ± z • s
Percentage
100- 97.5 %
8 0 . Si-* z=2
"reject 60 _ 50 % /
4 0 - / 3
20 - /  / a
O -
^
Allowable systematic error 
(ASE = 4)
0 1 2  3 ASE (units of s)
Fig. 6 Power functions for systematic error and for the three con­
trol rules x ± 2 s, x ± 3 s, and X ± 4 s. An assumed allowable sys­
tematic error of ASE — 4 is indicated. See table 3 for the respective 
P,v-values.
Three control rules of the type x ±  z X s with z =  2, 3, 
and 4, respectively, are illustrated in figure 6 and the 
allowable system atic  error (defined by analytical quality 
specifications) is here set to ASE =  4. The three control 
rules (with Ptv equal to 5%, 0.3%, and 0.01%), will have 
probabilities for detection of the systematic error (Pcd) 
of 97.5%, 84%, and 50%, respectively
Replicate control m easurem ents in a single run
By performing replicate measurements of the control 
sample within an analytical run and calculation of the 
mean of the replicates, x the variation of this mean, sx, 
is reduced by the square root of the number of replicates. 
Using four replicates, s* =  s/2 , which makes it possible 
to combine a low Pfr with a high Ped as illustrated in 
figure 7 for the control rule x ±  4 X s*. This control rule 
has the same P{V as the x ±  4 s rule and a higher Ped for
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Mean rule
Percentage x ± 4  s ,  =  x ± 4
100 
80
^reject 60
40
20
0
0 1 2 3 4 5 6 A SE (units of s)
Fig. 7 illustration o f  the advantages o f  the mean-rule by com bin­
ing a low P fr“Value with high power for detecting systematic eiTors. 
The mean-rule x ±  4 ss (o f  four replicates), combines the PcJ of 
the x ±  2 s rule and the P fr o f  the x ±  4 s rule (both with 1 determi­
nation).
the systematic error ASE =  4 than the x ±  2 s rule (for 
relations between within- and between-run variations, 
see 1. c. (27)).
This example demonstrates how powerful the combina­
tion of several control results can be. Westgard and ‘the 
Uppsala-group’ have described the power-functions for 
a long list of different control rules (5) and also with 
respect to separation of imprecision into within- and be- 
tween-run variation (27). Moreover, several books on 
the subject have been published (6 —8). It is out of the 
scope of this article to go into detail of the many pos­
sible rules and their power-functions, except for 
underlining the types of the best control rules for sys­
tematic errors: Mectn-ndes and Ciisum-ndes (in the latter 
results are cumulated over time) and for random error 
(X2) and the range-ndes. In the ‘Validator-programme*
described below3) many of these rules are included, and 
a few will be described in these guidelines.
Control Rules to Guarantee Quality with a Certain 
Probability
For the analytical quality specifications recommended 
by two European groups (12, 28) based on biological 
criteria and specified for both bias and imprecision, con­
trol rules can be decided from power-functions (5 , 7 , 8, 
27) when the inherent imprecision is known, i.e. when 
imprecision is estimated during stable analytical perfor­
mance.
The allowable total systematic error, S E T ( S E toicrabie) ( 6 ) ,  
is defined by the tolerable sum of the permanent analyti­
cal bias, Ba> and systematic error of runs (deviation 
from Ba ), A S E :
SEt =  B a +  ASE
and the allowable ASE can be calculated as the differ­
ence between SET and Ba, which thereby depends on 
the permanent bias, estimated from external quality as­
sessment or other ‘traceable’ materials. The power-func­
tions for four different control rules: x ±  2 s with two 
measurements of the control, x ±  3 s with four repli­
cates, and two control rules o f  the type x ±  z X  s*, both 
with four replicates, where z =  2.58 and 3, correspond­
ing to P fr =  1% and 0.2% (and symbolized by x0.oi and 
X0.002X respectively, are illustrated in figure 8 ,
3) QC V alidator™ , WesTgard® Quality Corporation, 112 Shore 
Road, P. 0 .  B ox 2026, O gunquit,  M E  03907, USA.
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Fig. 8 Power-functions for systematic error for four different 
control rules x ±  2 s (2 replicates), x ±  3 s (4 replicates), and the 
mean-rules x  ±  2.58 sx, and x ±  3 s* (both 4 replicates). P^-values 
o f  approx. 9%, 1%, 1%, and <  1% are shown together with the 
Pgj-values for ASE =  2 in the box at the right. Deviations in Pfr- 
and P ed-values from theoretical are due to the computer simulation
technique. Print out from  the 
footnote3)) with permission, 
dem o =  exam ple 
Smeas ~  s m easured
QC V alidator™ -program m e (see
bias m e a s =  bias m easured
b iasmatr =  bias due to m atrix
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Fig. 9 Power-functions for random error for four different control 
rules x ± 2 s (2 replicates), X ±  3 s (4 replicates), and the range- 
rules R0.0i R0.002 (both 4 replicates). Pfr-values of approx. 9%, 1%, 
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values from theoretical are due to the computer simulation
technique. Print out from the 
footnote3)) with permission, 
demo = example 
Smeas =  S measured 
biasmeas =  bias measured 
biasmatr = bias due to matrix
QC Validator rM-programme (see
which is a print out from the ‘Validator programme’, see 
below for details.
In the example, ASE is chosen arbitrarily equal to 2. 
The highest power is obtained for the x0,oi rule, whereas 
x ±  2 s and x0>()02 have the same power but with Pfr 
equal to 9% and 0.2%, respectively, and the power is 
still high.
The relation between allowable analytical random error, 
RET (REtolerable), and the inherent imprecision, s, is ex­
pressed by ARE, where ARE is the factor:
REt — ARE X s
For four different control rules for detection of random 
error, the power-functions are illustrated by a print out 
from the ‘Validator program’ in figure 9, choosing a 
ARE of 2.21. Two of the control rules are the same as 
for systematic error (fig. 8 , x ±  2 s with two measure­
ments o f the control, x ±  3 s with four replicates) and 
two are range Riles (difference between highest and low­
est control results, R) indicated by their P1V, R0>01 — 1% 
and R0.002 ~  0 .2 %, respectively.
Ped varies from 44% to 60% for the four control rules, 
but Pfr from a very low value, 0.2%, up to a high value 
o f 9%. The R 0.01-rule is the most powerful with Ped 
=  60%.
The Pfr and Ped for any control rule and any combination 
of inherent imprecision and allowable analytical error 
specific for all laboratories and analyses can be calcu­
lated by use of the power-functions found in articles and 
textbooks described above, or they can be calculated 
from the Validator-programme, described for other func­
tions below.
M inor system atic  errors
Minor systematic errors -  less than the acceptable sys­
tematic error — need not to be rejected. They will, how­
ever, result in an increased frequency of superfluous re­
je c tio n s , and should therefore be detected and corrected. 
The best method for detection of minor systematic errors 
is simple visual inspection of a control chart of the 
Shew hartAype. Further, one of the most effective control 
rules to verify such minor systematic errors is the so- 
called C usum -control ru le , where deviations of control 
results from the target value are cumulated over time 
(3 -5 ) .  For one of these Cusum-ruies a 0 ±  Vi X s in­
terval about the target value is considered neutral and 
only control values outside this interval will activate the 
control rule. For positive systematic error, the rule will 
be activated for control values above 0 + '/> X s and this 
value is subtracted from the following control values 
before cumulation. When this cumulated sum crosses 
zero, then the activation of the rule is abandoned, but if 
the cumulated sum exceeds the value of + or — 5 ,1 X s, 
then a persistent systematic error is disclosed. This does 
not mean that any run should be rejected, simply that 
trouble-shooting should start at the first suitable time 
(e.g. at the end of the day). Another good Cusum-rule 
is activated at 1 X s and stops at 2.7 X s. Rules of the 
type ‘moving average1 and ‘the multi-rule control pro­
cedure’ (as outlined in 1. c. (7)) are also effective in de­
tection of minor systematic errors.
Low  f r e q u e n c y  o f  e r ror s
When the frequency of errors is low, less power of the 
control system can be accepted and the number of con­
trol measurements as well as the PiV can be reduced (29).
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Reduction o f inherent imprecision
It is evident that improvement of the inherent precision, 
e. g. by change of instrument, will solve a lot of the 
above mentioned problems. First it improves the general 
analytical quality, but second, a reduction of imprecision 
to half the value will have the same effect as the mean 
rule in figure 7 (when calculations are performed using 
the “old” standard deviation).
The Validator-Programme
Westgard has designed a computer programme for opti­
mizing of control rules according to the above described 
principles and in relation to analytical quality specifica­
tions3). The computer programme presents the current 
knowledge on internal control rules for laboratory medi­
cine based on the pioneering work (3 -5 )  and on the 
relations to analytical quality specifications (28, 30— 
33). The two papers from 1994 compare analytical qual­
ity specifications derived in Europe (28) and in USA 
(34, 35).
Using the programme, it is possible to evaluate specific 
control mles for an individual laboratory, when analyti­
cal imprecision and bias are known. The programme, 
however, is designed for the US-CLIA-criteria, which 
are total error criteria, so the interpretation of the figures 
needs some introduction.
In order to use the programme for European analytical 
quality specifications the values for allowable bias,
Banow, and allowable imprecision, sanmv, the total allow­
able error, TEaliow> to be used is calculated as
T E a llo w  ^ a llo w  H-  1 . 6 5  X  S an ow
The factor 1.65 is valid for the 95% tolerance limits 
(2.33 for 99%).
Short description o f  the ' Validator programme ’
The ‘Validator programme’ is a computer programme 
for planning of internal control systems (control rules 
and number of replicates) when analytical quality speci­
fications are defined and the stable analytical perfor­
mance is known by its stable analytical bias and inherent 
analytical imprecision. The programme provides quick 
access to
a) power-function graphs,
b) critical-error graphs and
c) ‘OPSpecs carts’ (operational process specifications).
By entering the data for stable analytical imprecision 
and bias as well as for allowable total analytical error 
(plus additional information of the analytical quality, 
concentration for critical interpretations and matrix bias, 
which are not essential for understanding of the prin­
ciples) the three options can be investigated by graphs 
with tables. A great number of control rules with dif­
ferent numbers of replicates can be chosen and the ap­
propriate graphs are presented:
a) Power-function graphs are like figures 6 and 7, but 
not smooth due to the computer simulation technique
40.0
OPSpecs chart 36.0% with 90% AQA(SE)
35.0
?
1  30.0W
CQ
im m
*  25.0
> yo
2s 20.0 o u 
r t
.S 15.0
£A| 10.0 
o
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0.0 
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\  ^ \ < f c .
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\ \ \
5.00 10.00 15.00
Allowable imprecision meas°^
20.00
demo
Serum alanine aminotransferase
x_ =» 35.0 U/l
I s
smeas B 3,5 0y/° 
^ m e a s * 13-6 0^ 
biasmatx = 00%
Fig, .10 OPSpecs Chart for serum alanine aminotransferase with 
‘Allowable Total Error’ equal to 36%, from the allowable system­
atic error 13.6% and allowable random error 13.6% (13.6 + 1.65 
X 13,6) illustrating the same control rules as in figures 8 and 9 
and with a power of 90%. In this example an analytical bias of 
13.6% and an inherent imprecision of 3.5% are assumed, giving 
the ‘Operating Point’, which must be ‘within5 a control rule (to the 
left) if the power is sufficient. Deviations in P|-r- and Peti-values 
from theory are due to the computer simulation technique. The
heading is short for “operating specifications chart for 36% total 
error with 90% achieved quality assurance for systematic error”. 
Print out from the QC Validator™-programme (see footnote3))
with permission, 
demo = example
Smeas = s measured 
biasmeas — bias measured 
biasmn(r = bias due to matrix
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and lack of curve-fitting as seen from figures 8 and 9 
(which include critical errors).
b) Critical error graphs are identical to the power func­
tion graphs, but with additional introduction of the ‘criti­
cal error’ (figs. 8 and 9).
c) OPSpecs charts are more complicated (figs. 10 and 
11). The plot illustrates for different control rules the 
allowable total systematic error as function of allowable 
imprecision. Each line demonstrates the functional rela­
tionship (for the chosen control rule and number o f rep­
licates) between the two. A large systematic error is re­
lated to a small random error, and vice versa. The line 
to the right illustrates the limits for the hypothetical situ­
ation of total stability and without control rules. The ‘op­
erating point’ indicates the combination of the actual 
(and known) analytical bias and imprecision (inherent 
imprecision). This point must be to the left of the control 
line in order to assure the power (probability of error 
detection) as indicated in the top of the figure.
The programme also has an option for combining the 
analytical imprecision with the within-subject biological 
variation. This option, however, is more complicated 
and will not be referred to here.
Examples on design o f control rules
1. According to the European recommendations (28) the 
allowable bias and imprecision for the quantity serum 
alanine aminotransferase are 13.6% and 13.6%, respec-
a
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Fig. 11 OPSpecs Chart for serum urate with ‘Allowable Total Er­
ror’ equal to 10.9% (allowable bias = 4% and allowable im­
precision =  4.2% {4% + 1.65 X  4.2%}), for two different perfor­
mance characteristics:
a. Inherent imprecision to 2.2% and analytical bias to 4.0%* which 
can only give a power of 50%.
b. Inherent imprecision equal to 2.2% and analytical bias to 1.0%, 
whereby the 90% power can be obtained, using the same control 
rules.
Deviations in Pfr- and Ped-values from theory are due to the com 
puter simulation technique, Print out from the QC Validator™- 
programme (see footnote3)) with permission, 
demo = example
Smeas -  s measured 
hiasrneas = bias measured 
hiasniatr = bias due to matrix
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tively. TEaiiow is then equal to 13.6% +  1.65 X 13.6% 
=  36%. Using the same four control rules as used in 
figures 8 and 9, and assuming an inherent imprecision 
of 3.5%,. then the OPSpecs Chart from the Validator pro­
gramme gives a plot as shown in figure 10.
The axes are allowable bias and allowable imprecision, 
respectively. The curve Maximum limits o f stable pro­
cess illustrates the possible combinations of allowable 
bias and imprecision and the four other curves illustrate 
the four control rules, which will guarantee this with Pcd 
=  90% (shown above in fig. 10). The Operating Point 
illustrates a situation for a laboratory with a bias equal 
to the maximum allowable (13.6%) and an inherent im­
precision of 3.5%. This point must be to the left of the 
lines for control rules in order to guarantee the quality 
with the probability indicated. For this analytical compo­
nent this is obtained for all four control rules. On the 
right the control rules are described.
2. For serum urate, the European analytical quality
4
specifications are more demanding (26) with an allow­
able bias of 4.0% and an allowable imprecision of 4,2%. 
For a laboratory with a bias equivalent to the allowable 
level and an inherent imprecision of 2 .2%, the quality 
cannot be guaranteed with a Pcd =  90%, but only with 
50%, and only for two control rales, the x ±  2 s  with 
two replicates of the control, and with the combination 
of the two control rules Xo.oi and R0.0i for four replicates 
of the control, but very different in Pfr (fig. 11a).
If, however, the analytical bias is reduced to 1%, then 
the power can be obtained for both combinations of 
mean and range rules and for the g r i l l e  (with a Prr 
equal to 9%) as illustrated in figure l ib.
It should be noted that the combination of mean and 
range rules, each with very low Pfr of 0.2%, with com­
bined Pfr of 0.4%, are nearly as powerful as the other 
control rules with higher Pfr. This means that it is pos­
sible to keep the probability of false rejects low and at 
the same time have a high probability of error detection. 
By use of such a control system, there will be no reason 
for performing re-runs as a false reject signal will be 
seen only once a year, and in consequence, any reject 
signal means that there is an error and trouble-shooting 
should be activated. However, such control rules are best 
applied to batch oriented analytical systems rather than 
the dynamic random access approaches favoured at pre­
sent.
and when there are more ‘critical concentrations’, each 
should be treated in the same way as described above.
When more materials are used, then the Pfr of a run is 
changed as the probability of false rejections are inde­
pendent. The formula combining these Pfr-values to a 
total Pfr(total) is
Pfr(total) -  1 -  [1 -  P fr( l ) ]  X [1 — P fr(2)] ...
where the Pfr-values are given in fractions. For small 
values o f Pfr, however, the error of simple addition is 
negligible, e.g. Pfr(total) =  0.01 +  0.002 -  0.012.
For Ped the combined effect of two or more controls is 
more difficult to interpret, and combinations should be 
performed with caution. First, the Ped-values for random 
and systematic errors cannot be combined (as was the 
case also for one control). Second, the errors at two (or 
more) concentrations may be independent or even re­
verse, as seen for RIA curves, where the effect of errors 
on the S-shaped curve may be positive at one concentra­
tion and negative at another. Therefore, Ped-values can 
only be combined if they reflect the same error, which 
cannot be expected in general.
Often control materials at different concentrations have 
different purposes, and the results can be treated dif­
ferently. In some assays the ‘high control’ is more of a 
check of sufficient concentration of a certain reagent, 
e. g. serum lactate dehydrogenase, where it may control 
the required concentration of NADFI. In such a case rep­
licates are seldom needed and the demands may be more 
loose than at the critical concentration. In consequence, 
a lower Ped can be accepted and the Pfr can be kept low, 
e. g. <  0 .1%.
It is difficult to recommend how many control materials 
should be used, over which concentrations, and how 
often. An overall guideline could be to control the criti­
cal concentration or concentrations with control rules 
and replicated aiming for a high Ped for critical errors. 
The power, however, should be related to the stability of 
the analytical system and expected frequency of errors. 
Moreover, other concentrations as the high for which 
samples should be diluted and low, about the detection 
limit, if this has clinical relevance, may be controlled 
less intensely, e. g. once a run or even less, dependent 
on the frequency of changes of reagents and other key 
elements.
Other Control Systems
Control at Two or More Concentrations ^  ^  Lypes of analytical work and some analytical
Until now we have dealt with only one control material principles and instruments, the control systems and con-
where we have assumed that the concentration was close trol rules should be modified in order to optimize the
to the ‘critical concentration5. The number of concentra- system according to the special problems and to avoid
tions to be controlled depends on the use of the quantity, too stringent control systems.
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L Control o f fully automated single channel systems
These types of instruments are generally very stable with 
good precision and the possible errors for these types of 
systems are mainly related to batch-to-batch variations 
as the procedures in the laboratory are often reduced to 
a minimum. The principle control should be concen­
trated on each new batch, which should be evaluated 
carefully before it is introduced. The usual control rules 
can be used for this purpose, but often the general statis­
tical evaluations will be more useful as all results can 
be investigated together.
Many instruments have several ‘fail-safe’ procedures 
built in, which will stop the operation, when certain er­
rors occur, such as ‘unacceptable calibration curve\ 
‘wrong reagents’, ‘reverse rack’, etc. For such instal­
ments, the control systems may be loosened regarding 
Ped, but the Pfr must be kept low (if self-inflicted prob­
lems are to be avoided).
2. Control o f  random access and multichannel instru­
ments
For these instruments special attention should be paid 
when starting up (e, g. in the morning) using, e. g., two 
to four control measurements before running the patient 
samples (36). Then Cusum rules could be used during 
the production, for each quantity or in combination and 
combined with other control rules. Here, it is crucial to 
keep Pfr extremely low in order to avoid false reject 
signals from the repeated testing (cf. tab* 2 ).
In some instruments, the process is identical for several 
different quantities, so control results from all these can 
be combined e. g. in a Cusum-plot after ‘normalization’ 
of results. Thus, the number of control samples for each 
analysis can be reduced — often to only one control 
sample per quantity per day — but the frequency o f con­
trol should be adjusted according to the stability, i. e. the 
type and frequency of errors.
3. Near patient testing
For the type of instalments to be used outside the main 
laboratory, e.g.  dry chemistry systems, the quality de­
pends on the analyte, the users skills (sampling and 
handling o f the blood samples), and the instrument de­
sign. The problems related to the chemical part should 
be handled separately and the control should be per­
formed accordingly. Regarding the sampling and meas­
uring process, however, the control is very difficult. The 
control o f imprecision may be performed with lyophi- 
lized materials, whereas control o f systematic errors/bias 
often need matrix correct materials (37). Therefore, edu­
cation of the nurses or others involved in testing is 
essential. Real control can only be performed by simul­
taneous blood drawing by the nurse and a laboratory
technician, or by using a ‘stable’ person for the control, 
e. g. by sampling and measuring blood from the same 
healthy person once a month (38). The principle is that 
for many biological quantities, the within-subject bio­
logical variation is rather low for healthy individuals, 
even for blood glucose (fasting). By use of a ‘stable’ 
person (living control) it is possible to monitor the com­
bined variation o f within-subject biology, sampling, 
handling of the specimen, and the analytical process. 
For quantities with moderate within-subject biological 
variation mean-values from more than one ‘living con­
trol’ could be used. The process, however, is time con­
suming and is only useful for occasional control, e.g. 
once a month.
4. Control o f unstable quantities
For unstable quantities, e, g. haematological analyses, a 
short-term control procedure can be obtained by fresh 
stabilized blood, which can be used as long as the com­
ponents is stable. If the in vitro disappearance rate is 
known, as for fractions of reticulocytes, the control ma­
terial may be used for longer periods, as the disappear­
ance is predictable. Since the patient results are the final 
products and they make up the majority of analytical 
outcome, it might be tempting to extract information 
about analytical quality from these data (39—41). The 
validity of patient results in analytical control as a sub­
stitute for control samples may be disputed, but median 
and distribution of patient results may be used as a final 
check of the production of larger series. In principle the 
median of patients results can be used after principles 
comparable to the mean-rules describes above, but it 
may be more difficult to give a reliable estimate of the 
standard deviation to be used. When stable and reliable 
control materials are difficult to obtain, however, the use 
of patient results in control of the analytical quality may 
be superior. Bidl et al. (42) have evaluated mean-rules 
to be used in haematology and Cembrowski Sc Westgard 
(43) have assessed these control systems in comparison 
with traditional IQC, with results in favour of the patient 
control system. It must be remembered, however, that 
the ‘quality of the patient data’ must be documented. 
But with the increasing power of computers in labora­
tory medicine the patient data for such a control may 
make it valid for internal control of many analytical pro­
cedures.
5. Control o f components measured, on an ordinal- or 
nominal-scale
The control is often more simple but also less convinc­
ing from a statistical point of view. In practice two con­
trol samples are often run, one negative and one posi­
tive. For genetic mutants (DNA analyses) this is suffi­
cient, but for many other analytes, e. g. HIV-antibodies, 
the more reliable control might be about the detection
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limit. If a control with concentration near to the detec­
tion limit should be used, then the percentage of positive 
results should be a known value dependent on the defini­
tion of the detection limit and acceptance of dispersion. 
A great number of measurements will be needed to esti­
mate this percentage.
Retrospective Documentation of Analytical Quality
In most laboratories, control results are also used for 
calculation of the analytical imprecision for each 
method. This technique implies, however, a sampling 
bias, as the results have first been used in the control 
procedure (this can partly be avoided if all control data 
are considered, including those rejected). An indepen­
dent estimate can only be performed by independent 
documentation, e. g. use of a material which is measured 
as a patient sample, but not used in the control process. 
All results for this material from accepted runs can then 
be used for calculation of the analytical imprecision.
Relation to External Quality Assessment
As stated above, internal control is related to the variable 
factors, cannot in general be used for assessing ‘trace- 
ability’ (19, 20) and can only be used for control of 
specificity by use of combination o f samples, selected 
for the purpose. It is, however, important to tie the in­
ternal control to the external system in order to make it 
reliable for monitoring of the long-term stability with a 
known and accepted bias. Therefore, target values 
should be assigned to the internal control materials when 
the traceability is assessed, by use of (international) ref­
erence preparations, external assessment using high 
quality materials with traceable target values (only 
known retrospectively), e. g. by running both types of 
materials in several runs using replicates. It is stressed 
that the control materials must be independent of the 
producer of kits and calibrators in use as independency 
is essential for reliable internal control. A scheme for 
integration of internal control and external assessment 
should be designed with number of replicates for in­
ternal as well as external materials related to the analyti­
cal quality specifications and confidence intervals esti­
mated from the known inherent analytical imprecision. 
This increases the demands for reliable external control 
materials with target values traceable to internationally 
accepted certified reference materials or reference meth­
ods.
Relations to Other Recommendations
Guidelines for internal control have been published for 
the concentration levels of control materials, the number 
of replicates of each material, and control rules to be
used (44). NCCLS (45) has defined that ‘quality control 
samples must be analyzed at least once during each user- 
defined analytical run* and the German “Richtlinien” 
(46, 47) require precision control at ‘normal range’ in 
every 4th series. The purpose o f ‘Richtlinien’ and 
thereby, the German control system is a system with 
traceable values which in co-ordination with a firm in­
ternal control system is believed to secure a high level 
of analytical quality IUPAC (48) recommends control 
charts of the Shewhcirt type and also deals with analysis 
in duplicate.
In principle we agree with all the recommendations from 
these guidelines. We find, however, that they point too 
little to the purpose of improving the analytical perfor­
mance and prevention o f  errors, which must be more 
interesting than the control. Here, the IQC is an indis­
pensable part ~  but only a part — of the whole process 
as described in figure 1, In consequence, we do not rec­
ommend a certain number o f control materials and a 
defined number of replicates, In contrast, the control 
system should be flexible and related to the current sta­
bility (or lack of stability) of the analytical system.
As mentioned above control does not improve analytical 
quality by itself, but is useful in detection of errors. 
When errors occur, however, it is important to do the 
trouble-shooting, and — not only correct the error — but 
investigate the cause, and finally make systems to pre­
vent the same errror from occuring again (fail-safe pro­
cedures). Therefore, a control system should not be 
static, but dynamic, and one prerequisite is a control 
system with a very low Pfr, in order to reduce frustra­
tions from unnecessary reject signals.
Guidelines
The internal control system should be problem related 
and used as an integrated part of a more dynamic system 
for quality improvement.
It should be linked to the external system with reliable 
control materials with concentrations ‘traceable1 to in­
ternationally accepted certified reference materials or 
reference methods, through a design which guarantees 
the further 'traceability' in the laboratory.
It should further be related to the analytical quality spec­
ifications, e. g.
C V ana|yi{cal <  0 .5  X  CV^vithin-subject &fld 
B i a s anaiyticai ^  0 .2 5  X
(C V w ithin-subjcct CV betw een-subject)
When errors are frequent the Peci should be high, but 
with a very low Pfr, in order to stimulate intensive trou­
ble-shooting and build up a fail-safe system, which will 
lower error frequency, and thereby, open for a looser 
control system, but still with a low P ^
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Other control systems and check procedures (built into 
the equipment or information from other analytes mea­
sured on the same equipment) should be integrated into 
the total control system. Where possible, median and 
distribution of patient results should be taken into con­
sideration (e.g. haematology where the indices are 
rather constant), blit it must be remembered that patient 
results can give supplementary information, but they 
cannot replace all control samples.
Control charts of the Shewhart type should be shown on 
the control screens or printed out for visual inspection 
for minor systematic errors and supplemented with a 
Cusum-rule or comparable.
It is better to prevent errors than to correct them and to 
reduce imprecision, which will make it easier to com­
bine a low P1V with a high PQd.
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